176 related articles for article (PubMed ID: 35864544)
1. Transplanted allogeneic cardiac progenitor cells secrete GDF-15 and stimulate an active immune remodeling process in the ischemic myocardium.
Mishra R; Saha P; Datla SR; Mellacheruvu P; Gunasekaran M; Guru SA; Fu X; Chen L; Bolli R; Sharma S; Kaushal S
J Transl Med; 2022 Jul; 20(1):323. PubMed ID: 35864544
[TBL] [Abstract][Full Text] [Related]
2. Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction.
Iso Y; Rao KS; Poole CN; Zaman AK; Curril I; Sobel BE; Kajstura J; Anversa P; Spees JL
Stem Cells; 2014 Mar; 32(3):674-83. PubMed ID: 24022988
[TBL] [Abstract][Full Text] [Related]
3. Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction.
Reich H; Tseliou E; de Couto G; Angert D; Valle J; Kubota Y; Luthringer D; Mirocha J; Sun B; Smith RR; Marbán L; Marbán E
J Heart Lung Transplant; 2016 Nov; 35(11):1348-1357. PubMed ID: 27342903
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year.
Tang XL; Li Q; Rokosh G; Sanganalmath SK; Chen N; Ou Q; Stowers H; Hunt G; Bolli R
Circ Res; 2016 Apr; 118(7):1091-105. PubMed ID: 26838790
[TBL] [Abstract][Full Text] [Related]
6. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
[TBL] [Abstract][Full Text] [Related]
7. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction.
Garbayo E; Ruiz-Villalba A; Hernandez SC; Saludas L; Abizanda G; Pelacho B; Roncal C; Sanchez B; Palacios I; Prósper F; Blanco-Prieto MJ
Acta Biomater; 2021 May; 126():394-407. PubMed ID: 33716175
[TBL] [Abstract][Full Text] [Related]
8. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function.
Rota M; Padin-Iruegas ME; Misao Y; De Angelis A; Maestroni S; Ferreira-Martins J; Fiumana E; Rastaldo R; Arcarese ML; Mitchell TS; Boni A; Bolli R; Urbanek K; Hosoda T; Anversa P; Leri A; Kajstura J
Circ Res; 2008 Jul; 103(1):107-16. PubMed ID: 18556576
[TBL] [Abstract][Full Text] [Related]
9. Circulating exosomes derived from transplanted progenitor cells aid the functional recovery of ischemic myocardium.
Saha P; Sharma S; Korutla L; Datla SR; Shoja-Taheri F; Mishra R; Bigham GE; Sarkar M; Morales D; Bittle G; Gunasekaran M; Ambastha C; Arfat MY; Li D; Habertheuer A; Hu R; Platt MO; Yang P; Davis ME; Vallabhajosyula P; Kaushal S
Sci Transl Med; 2019 May; 11(493):. PubMed ID: 31118291
[TBL] [Abstract][Full Text] [Related]
10. Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct.
Van't Hof W; Mal N; Huang Y; Zhang M; Popovic Z; Forudi F; Deans R; Penn MS
Cytotherapy; 2007; 9(5):477-87. PubMed ID: 17786609
[TBL] [Abstract][Full Text] [Related]
11. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction.
Padin-Iruegas ME; Misao Y; Davis ME; Segers VF; Esposito G; Tokunou T; Urbanek K; Hosoda T; Rota M; Anversa P; Leri A; Lee RT; Kajstura J
Circulation; 2009 Sep; 120(10):876-87. PubMed ID: 19704095
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains.
Tseliou E; Pollan S; Malliaras K; Terrovitis J; Sun B; Galang G; Marbán L; Luthringer D; Marbán E
J Am Coll Cardiol; 2013 Mar; 61(10):1108-19. PubMed ID: 23352785
[TBL] [Abstract][Full Text] [Related]
13. Pre-Treatment with Melatonin Enhances Therapeutic Efficacy of Cardiac Progenitor Cells for Myocardial Infarction.
Ma W; He F; Ding F; Zhang L; Huang Q; Bi C; Wang X; Hua B; Yang F; Yuan Y; Han Z; Jin M; Liu T; Yu Y; Cai B; Lu Y; Du Z
Cell Physiol Biochem; 2018; 47(3):1287-1298. PubMed ID: 29913449
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction.
Tang XL; Rokosh G; Sanganalmath SK; Yuan F; Sato H; Mu J; Dai S; Li C; Chen N; Peng Y; Dawn B; Hunt G; Leri A; Kajstura J; Tiwari S; Shirk G; Anversa P; Bolli R
Circulation; 2010 Jan; 121(2):293-305. PubMed ID: 20048209
[TBL] [Abstract][Full Text] [Related]
15. Sca-1+ cardiac progenitor cell therapy with cells overexpressing integrin-linked kinase improves cardiac function after myocardial infarction.
Ling L; Bai J; Gu R; Jiang C; Li R; Kang L; Ferro A; Xu B
Transplantation; 2013 May; 95(10):1187-96. PubMed ID: 23598943
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
[TBL] [Abstract][Full Text] [Related]
17. Pericardial Grafting of Cardiac Progenitor Cells in Self-Assembling Peptide Scaffold Improves Cardiac Function After Myocardial Infarction.
Kanda M; Nagai T; Kondo N; Matsuura K; Akazawa H; Komuro I; Kobayashi Y
Cell Transplant; 2023; 32():9636897231174078. PubMed ID: 37191272
[TBL] [Abstract][Full Text] [Related]
18. Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose.
Tang XL; Nakamura S; Li Q; Wysoczynski M; Gumpert AM; Wu WJ; Hunt G; Stowers H; Ou Q; Bolli R
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440036
[TBL] [Abstract][Full Text] [Related]
19. Irisin promotes cardiac progenitor cell-induced myocardial repair and functional improvement in infarcted heart.
Zhao YT; Wang J; Yano N; Zhang LX; Wang H; Zhang S; Qin G; Dubielecka PM; Zhuang S; Liu PY; Chin YE; Zhao TC
J Cell Physiol; 2019 Feb; 234(2):1671-1681. PubMed ID: 30171682
[TBL] [Abstract][Full Text] [Related]
20. Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer.
Ong SG; Lee WH; Huang M; Dey D; Kodo K; Sanchez-Freire V; Gold JD; Wu JC
Circulation; 2014 Sep; 130(11 Suppl 1):S60-9. PubMed ID: 25200057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
